Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,251
+6.34%
|
$290,232
$232.0 P/Share
|
|
Mar 15
2022
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
68
-0.82%
|
$15,776
$232.0 P/Share
|
|
Mar 15
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,153
-5.56%
|
$267,496
$232.0 P/Share
|
|
Mar 15
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
BUY
Grant, award, or other acquisition
|
Direct |
2,692
+11.5%
|
$624,544
$232.0 P/Share
|
|
Mar 15
2022
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-2.97%
|
$251,720
$232.0 P/Share
|
|
Mar 15
2022
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,841
+7.21%
|
$659,112
$232.0 P/Share
|
|
Mar 15
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
792
-2.04%
|
$183,744
$232.0 P/Share
|
|
Mar 15
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,393
+5.8%
|
$555,176
$232.0 P/Share
|
|
Mar 14
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Open market or private sale
|
Direct |
4,000
-9.08%
|
$916,000
$229.81 P/Share
|
|
Mar 11
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Bona fide gift
|
Direct |
283
-0.7%
|
-
|
|
Mar 11
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Open market or private sale
|
Direct |
4,000
-9.02%
|
$908,000
$227.15 P/Share
|
|
Mar 11
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Open market or private sale
|
Direct |
3,000
-11.98%
|
$687,000
$229.0 P/Share
|
|
Mar 03
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,000
-5.2%
|
$488,000
$244.0 P/Share
|
|
Mar 01
2022
|
Daniel R Glickman Director |
SELL
Open market or private sale
|
Direct |
750
-5.0%
|
$175,500
$234.3 P/Share
|
|
Feb 24
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.76%
|
$351,000
$234.01 P/Share
|
|
Feb 14
2022
|
Sunil Cutinho Chief Information Officer |
SELL
Open market or private sale
|
Direct |
4,900
-11.32%
|
$1,161,300
$237.96 P/Share
|
|
Feb 10
2022
|
Kevin Kometer Sr MD Chief Information Office |
SELL
Open market or private sale
|
Direct |
13,500
-6.21%
|
$3,294,000
$244.29 P/Share
|
|
Feb 10
2022
|
Elizabeth A Cook Director |
SELL
Open market or private sale
|
Indirect |
1,000
-5.07%
|
$244,000
$244.25 P/Share
|
|
Feb 10
2022
|
Charles P Carey Director |
SELL
Open market or private sale
|
Indirect |
3,000
-15.2%
|
$732,000
$244.36 P/Share
|
|
Jan 25
2022
|
Dennis Chookaszian Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+1.36%
|
-
|
|
Jan 25
2022
|
Howard J Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.1%
|
$16,575
$221.79 P/Share
|
|
Jan 25
2022
|
Dennis Suskind Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+1.46%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Ana Dutra Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.72%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Phyllis M Lockett Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+2.39%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Terry L Savage Director |
BUY
Grant, award, or other acquisition
|
Indirect |
47
+0.25%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
William R Shepard Director |
BUY
Grant, award, or other acquisition
|
Indirect |
75
+0.04%
|
$16,575
$221.79 P/Share
|
|
Jan 25
2022
|
Bryan T Durkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.07%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Rahael Seifu Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+3.46%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Larry G Gerdes Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.2%
|
$16,575
$221.79 P/Share
|
|
Jan 25
2022
|
Daniel G Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+2.39%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Martin J Gepsman Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.2%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Daniel R Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.31%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Timothy S. Bitsberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.46%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Deborah J Lucas Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+1.77%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Charles P Carey Director |
BUY
Grant, award, or other acquisition
|
Indirect |
75
+1.56%
|
$16,575
$221.79 P/Share
|
|
Jan 25
2022
|
Patrick J Mulchrone Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.09%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
47
+3.43%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Patrick W Maloney Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+3.45%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
William W Hobert Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.09%
|
$16,575
$221.79 P/Share
|
|
Jan 25
2022
|
Elizabeth A Cook Director |
BUY
Grant, award, or other acquisition
|
Indirect |
47
+0.24%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Robert J Tierney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+2.39%
|
$10,387
$221.79 P/Share
|
|
Jan 14
2022
|
William R Shepard Director |
BUY
Small Acquisition
|
Direct |
30
+1.4%
|
$6,660
$222.28 P/Share
|
|
Dec 16
2021
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-0.34%
|
$14,885
$229.09 P/Share
|
|
Dec 10
2021
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
450
-2.3%
|
-
|
|
Dec 07
2021
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
500
-2.09%
|
$115,500
$231.0 P/Share
|
|
Dec 02
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Bona fide gift
|
Indirect |
3,700
+19.68%
|
-
|
|
Dec 02
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Bona fide gift
|
Indirect |
3,700
-20.96%
|
-
|
|
Dec 02
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Open market or private sale
|
Indirect |
4,500
-28.29%
|
$1,017,000
$226.84 P/Share
|
|
Dec 01
2021
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
90
-0.46%
|
-
|
|
Nov 12
2021
|
Howard J Siegel Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.6%
|
$1,115,000
$223.92 P/Share
|